CD25-bindende Moleküle
European patent · EP0449769 · Deleted
Register entry
- Publication number
- EP0449769
- Application number
- EP91810166
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Mar 13, 1991
- Published
- Oct 2, 1991
- Granted
- Dec 15, 1993
- Deleted
- Mar 12, 2011
- Reason
- Maximum term reached
- IPC classes
- C07K 15/28 (1990.01)C12N 15/13 (2006.01)C12P 21/08 (2006.01)A61K 39/395 (2006.01)
- Priority
- GB A 9005962 16.03.1990GB A 9019323 05.09.1990
- Filing language
- English
- Source
- Swissreg
Supplementary protection certificates
A certificate extends the patent’s protection for a medicine or a plant protection product authorised in Switzerland.
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Mar 14, 2011
Maximum term reached
Published in Swissreg on 14.03.2011
- May 15, 1997
Address changed
- Owner
- Sandoz AG, Lichtstrasse 35, 4002 Basel, Royal Free Hospital School of, Medicine, Rowland Hill Street, London NW3, United Kingdom → Royal Free Hospital School of, Medicine, Rowland Hill Street, London NW3, United Kingdom, Novartis AG, Schwarzwaldallee 215, 4058 Basel
Published in PIDTJ No 9 in 1997
- Jan 31, 1994
Granted
Published in PIDTJ No 2 in 1994
Parties
Holder
Inventor
Amlot, Peter Lloyd
London N9 9BL, GB
Akbar, Arne Nalpon
Richmond, Surrey TW94LD, GB
Heinrich, Günther
CH-4125 Riehen
Cammisuli, Salvatore
CH-4153 Reinach
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.